A two-dimensional lanthanum(III) porous coordination polymer was prepared, characterized and applied as an efficient adsorbent for the removal of uranium from aqueous solution. Lanthanum(III) was the metal center of MOFs, and the deprotonated anions of pyridine-2,6-dicarboxylic acid (H 2 PDA), PDA 2− was the organic ligand, this MOF was name as La-PDA, which was synthesized by hydrothermal reaction method. Scanning electron microscope (SEM), Fourier transform infrared (FTIR), powder X-ray diffraction (PXRD) and thermal gravimetric (TG) analysis were used for characterization, and the results indicated that the La-PDA composites were successfully prepared. Compared with traditional adsorbents of uranium, La-PDA showed excellent adsorption properties. The adsorption capacity was 247.6 mg g −1 at 298 K and pH 4.0. The adsorption equilibrium achieved within 120 min, and the adsorption process was exothermic and spontaneous. The absorption mechanism of La-PDA was also explored, from the XPS spectra, the pyridine-like nitrogen atoms (C=N–C) and carboxyl oxygen atoms (–COO–) contributed to the adsorption of uranium. The results suggested that PDA 2− was a potential ligand of uranium adsorption, La-PDA composites were effective adsorbents for the removal of uranium from aqueous solution.
Dongze Ren,Mingjie Liu,Min Cao,Shan Wang,Sixing Fan,Mozhen Liu,Jianbin Zhang,Huijun Sun
Osteoarthritis (OA) is an irreversible degenerative disease of articular cartilage that commonly occurs in the middle-aged and elderly people. However, effective intervention for early and middle-stage OA is still limited due to its complex and multifactorial nature. Excessive reactive oxygen species (ROS) and the inflammatory microenvironment are considered to play crucial roles in the occurrence and development of OA. Here, a novel HPB@LA@PDA nanoplatform is designed, which utilizes the mimicking enzyme activity of hollow prussian blue (HPB) nanozymes and antioxidant activity of lipoic acid (LA), to synergistically scavenge ROS and remodel the OA microenvironment. HPB@LA@PDA was firstly synthesized and the characterizations were confirmed by TEM, DLS, XPS, FTIR, UV–Vis, and XRD methods. It exhibited excellent multienzyme-like (SOD, GPx, CAT and POD-like) activities and antioxidant activities, converting •O 2 − , H 2 O 2 , •OH and reactive nitrogen species into harmless products. Importantly, at both the cellular and animal levels, we found HPB@LA@PDA could effectively scavenge excess ROS, protect against ROS-induced oxidative stress, apoptosis and ferroptosis, and ameliorate mitochondrial dysfunction, reduce inflammatory expression, and inhibit macrophage polarization in the chondrocytes. Finally, the results of in vivo study demonstrated that HPB@LA@PDA exhibited good biocompatibility and excellent therapeutic efficacy in the OA rat model. Micro-CT scaning, histopathological and immunofluorescence staining and western blotting analysis confirmed that HPB@LA@PDA attenuated the progression of OA by way of scavenging reactive oxygen species and remodelling the inflammatory microenvironment. The combination of drug and nanoenzyme vehicle offers a promising prospect for the treatment of various inflammatory diseases, including OA.
危险品化学品经营许可证（带存储）